Skip to main content
CTRE
NYSE Real Estate & Construction

CareTrust Q3 Net Income Rises to $83.7M; $2.0B Revolver and £552M UK Close Detailed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
7
Price
$37.18
Mkt Cap
$8.785B
52W Low
$34.55
52W High
$43.62
52W Position info
7.6% above low
Off High info
15% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CTRE is trading near its 52-week low of $34.55 (7.6% above the low).

Summary

CareTrust reported Q3 2026 net income of $83.7 million ($0.35 per share) on revenue of $176.4 million, up from $132.4 million a year earlier, with total debt rising to $2.075 billion to fund acquisitions. Post-quarter it closed 23 UK care homes for £552 million and signed a $2.0 billion revolver plus $700 million term loan.


Key Events · Earnings and Guidance · CTRE

  • Q3 Net Income $83.7 Million

    Net income attributable to CareTrust was $83.653 million, or $0.35 basic and diluted per share, versus $74.901 million in Q3 2025; nine-month net income was $252.859 million.

  • Revenue Up 33% Year Over Year

    Total Q3 2026 revenues were $176.360 million versus $132.444 million a year earlier, driven by rental income of $127.236 million and interest income from financing receivables of $14.030 million.

  • Debt Rises to Fund Acquisitions

    Total debt reached $2.075 billion at September 30, 2026 versus $900 million at December 31, 2025, including $1.175 billion drawn on the revolver; total assets grew to $7.706 billion from $5.148 billion.

  • Transaction Costs and Loan Marks

    Q3 included $8.933 million of transaction costs, primarily unsuccessful acquisition pursuit costs, and a $7.262 million non-cash unrealized loss on other real estate related investments.


Analysis · CTRE · Real Estate & Construction

CareTrust's third quarter showed the acquisition machine running: revenue rose to $176.4 million from $132.4 million a year ago and net income attributable to the company reached $83.7 million, or $0.35 per share. The balance sheet tells the funding story — total debt jumped to $2.075 billion from $900 million at year-end, with $1.175 billion drawn on the revolver, and share count rose to 257.5 million from 222.7 million as equity was issued. Two items deserve attention: $8.9 million of transaction costs from deals that did not close, and a $7.3 million non-cash unrealized loss marking the loan book to market. The October 29 refinancing into a $2.0 billion revolver plus a new $700 million term loan, and the October 1 close of 23 UK care homes for £552 million at £32.2 million initial annual rent, are the operating backdrop for the next several quarters.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTRE was trading at $37.18 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $8.8B. The 52-week trading range was $34.55 to $43.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTRE - Latest Insights

CTRE
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.07
Real-time Price: $37.22 info
Change: -$0.850 (-2%) info
Market Cap: $9.469B info
CTRE
Nov 12, 2026, 12:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $37.52
Real-time Price: $37.22 info
Change: -$0.2995 (-0.80%) info
Market Cap: $9.469B info
CTRE
Nov 11, 2026, 4:37 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.04
Real-time Price: $37.22 info
Change: -$1.82 (-5%) info
Market Cap: $9.469B info
CTRE
Nov 05, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.22 info
Change: +$0.040 (+0.11%) info
Market Cap: $9.469B info
CTRE
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.22 info
Change: +$0.040 (+0.11%) info
Market Cap: $9.469B info